Navigation Links
VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting

GF Trap-Eye for the treatment of wet AMD, diabetic eye diseases, and other eye diseases and disorders. Bayer HealthCare AG and Regeneron will jointly commercialize the VEGF Trap-Eye outside the United States, and Regeneron maintains exclusive rights in the United States.

In the Phase 2 wet AMD trial, data were presented from a pre-planned interim analysis of the first 78 patients who completed 12 weeks of the study. The randomized, multi-center trial involves 150 patients who were randomized to 5 groups and treated with the VEGF Trap-Eye in one eye. Two groups received either 0.5 or 2.0 milligrams (mg) of VEGF Trap-Eye administered every 4 weeks, and three groups received a single dose of 0.5, 2.0, or 4.0 mg of VEGF Trap-Eye. Patients were monitored for safety, retinal thickness, and visual acuity over 12 weeks. The VEGF Trap-Eye met its primary endpoint of a statistically significant reduction in retinal thickness after 12 weeks compared with baseline (all groups combined, decrease of 135 microns, p less than 0.0001). Mean change in visual acuity, a key secondary endpoint of the study, also demonstrated a statistically significant improvement (all groups combined, increase of 5.9 letters, p less than 0.0001). There were no drug-related serious adverse events, and treatment with the VEGF Trap-Eye was generally well-tolerated. The most common adverse events were those typically associated with intravitreal injections. Interim data for all dose groups were presented at the ARVO meeting. The Phase 2 wet AMD study is now fully enrolled and results for all patients will be presented at a future scientific meeting.

Encouraging results were also presented from a Phase 1 study of VEGF Trap-Eye in DME. In this open-label safety study, the VEGF Trap-Eye was administered as a single 4.0 mg intravitreal injection to 5 patients with longstanding diabetes and multiple prior treatments for DME. The single injection resulted in a marked decrease in mean central retina
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: VEGF Trap Eye Phase Wet AMD Results Reported ARVO Annual Meeting
(Date:9/12/2014)... DALLAS , September 12, 2014 ... Cans Market by Application [Beverages (Alcoholic, CSD, Sports & ... Food, Pet Food, Meat & Seafood)], by Material ... published by MarketsandMarkets, defines and segments the Food ... projections of each application in terms of volumes ...
(Date:9/12/2014)... , Sept. 12, 2014  Royal Philips (NYSE: ... number of innovations at ASTRO,s 56th Annual Meeting ... solutions that increase workflow automation, confidence, consistency and accuracy ... and enhancing patient-centric care, these radiation oncology solutions underscore ... a more personalized approach to medicine. "Philips ...
(Date:9/12/2014)... DUBLIN , Sept. 12, 2014 Research ... Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast - ... cancer is the most common cancer among women in both ... was in double digit Billion US$ for 2013. ... cancer screening globally. China is expected ...
Breaking Medicine Technology:Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 2Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 3Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 4Philips Demonstrates Commitment to Radiation Oncology Solutions at ASTRO 2014 2Philips Demonstrates Commitment to Radiation Oncology Solutions at ASTRO 2014 3Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast - Worldwide 2Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast - Worldwide 3Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast - Worldwide 4
... March 7, 2011 Ajinomoto Co., a leader ... safe, effective nutraceutical solutions, has announced that its ... federal trademark registration, (®), on the Principal Register ...  The trademark is the latest milestone for Capsiate ...
... 7, 2011 HGI Global Holdings, Inc., a leading ... today announced the appointment of Michael B. Petras, Jr. ... Mr. Petras, 43, joins HGI from GE Lighting, ... (NYSE: GE ) where he served as ...
Cached Medicine Technology:Ajinomoto Co.'s Capsiate Natura® Reaches New Milestone 2Michael Petras, Former CEO of GE Lighting, Named CEO of Cleveland-Based Specialty Medical Supplies Leader 2Michael Petras, Former CEO of GE Lighting, Named CEO of Cleveland-Based Specialty Medical Supplies Leader 3
(Date:9/14/2014)... (PRWEB) September 14, 2014 Globally the ... America, mainly in the US, followed by Europe and ... therapy centers and many are in development phase or ... in different countries as various governments are showing interest ... in Europe, mainly because of low awareness of this ...
(Date:9/14/2014)... Columbus, OH (PRWEB) September 14, 2014 A ... Wright & Schulte LLC on behalf of a Franklin ... DePuy metal-on-metal hip implant. The metal-on-metal hip lawsuit filed ... states that the Ohio man was 40 years old when ... hip. (Case No. 3:14-cv-02428-K) According to the hip ...
(Date:9/13/2014)... Over the past five years, ... Australia have shown signs of struggle. “The ... goods has caused Australian consumers to turn away ... IBISWorld industry analyst Ryan Lin. This trend has ... health consciousness, which has alerted the Australian population ...
(Date:9/13/2014)... MillionaireSinglesDating.com is a millionaire dating site ... dating services provider, which also launched the leading ... daddy site , SugarDaddyMeet.com, and the leading ... recently reached 2 million users milestone. , MillionaireSinglesDating.com ... include CEOs, lawyers, doctors, pro athletes, models and ...
(Date:9/13/2014)... September 13, 2014 Bedros Keuilian, founder of ... fitness marketing coach , has always been an advocate of ... most useful days are over, but the post explains that ... need to change. , “A lot of people think of ... says Keuilian. “They run a special and the only thing ...
Breaking Medicine News(10 mins):Health News:Global Proton Therapy Market Trends and 2018 Opportunities Now Available at MarketReportsOnline.com 2Health News:Global Proton Therapy Market Trends and 2018 Opportunities Now Available at MarketReportsOnline.com 3Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 2Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 3Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 4Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 5Health News:Confectionery Manufacturing in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Confectionery Manufacturing in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:MillionaireSinglesDating.com Reaches 2 Million Users Milestone 2Health News:Renegade Fitness Marketing Expert Reveals How Personal Trainers Can Use Groupon More Effectively to Sign New Clients 2Health News:Renegade Fitness Marketing Expert Reveals How Personal Trainers Can Use Groupon More Effectively to Sign New Clients 3
... for Research in Vision and Ophthalmology is honored to ... of ARVO Fellow recognizes members for their accomplishments, leadership ... this honor, ARVO anticipates that Fellows will continue to ... careers in vision and ophthalmology research and to further ...
... ... concerned with the pathogenesis of disease at the molecular level, in order to design ... ... time a person experiences symptoms of an aggressive brain tumor it is often too ...
... ALS ( Lou Gehrig,s disease) named Service Related Disorder Earlier ... In recognition of multiple studies connecting ALS to military ... December 22, 2009 , provided for the grant of ... Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig,s disease).  Deemed a ...
... , , DETROIT , ... today announced that its Board of Directors has set the date for ... for shareholders eligible to vote at the meeting.   , The Annual ... at 10:30 am EST at the MGM Grand Hotel, 1777 ...
... cuts that risk significantly, study finds , TUESDAY, Jan. 12 ... increase in resting heart rate boosts the risk of dying ... has found. , Norwegian researchers tracked the health of about ... of 18 years. During that time, 6,033 men and 4,442 ...
... Frank conversations about hospice and preferred place of death are ... -- Terminally ill patients have much to consider, from whether ... to whether they want doctors to continue aggressive treatment or ... months. , Yet those difficult, emotional conversations aren,t happening nearly ...
Cached Medicine News:Health News:ARVO announces 2010 fellows 2Health News:ARVO announces 2010 fellows 3Health News:ARVO announces 2010 fellows 4Health News:News from the Latest Issue of Molecular Medicine 2Health News:ALS Therapy Development Institute Receives $1.6 Million Grant From the Department of Defense for Lou Gehrig's Disease Research 2Health News:ALS Therapy Development Institute Receives $1.6 Million Grant From the Department of Defense for Lou Gehrig's Disease Research 3Health News:ALS Therapy Development Institute Receives $1.6 Million Grant From the Department of Defense for Lou Gehrig's Disease Research 4Health News:United American Healthcare Corporation Announces Meeting Date and Record Date for Annual Meeting of Shareholders 2Health News:United American Healthcare Corporation Announces Meeting Date and Record Date for Annual Meeting of Shareholders 3Health News:Faster Heart Rate May Raise Risk of Heart Attack Death 2Health News:Doctors Put Off End-of-Life Talks With Terminally Ill 2Health News:Doctors Put Off End-of-Life Talks With Terminally Ill 3
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... incorporate a layered design unique in the ... to prevent stray electrosurgical burns along the ... failure or capacitive coupling; a well-documented patient ... all AEM Instruments provides a neutral return ...
... incorporate a layered design unique in the ... to prevent stray electrosurgical burns along the ... failure or capacitive coupling; a well-documented patient ... all AEM Instruments provides a neutral return ...
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
Medicine Products: